BRIXADI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
58284-264 -
Package NDC
58284-264-01 -
Application number
NDA210136 -
SPL ID
4e1985eb-1302-42e0-ac79-10b0a492966a -
SPL set ID
5d8a8fd0-8619-422a-a664-d1d2e8970f48 -
UNII
40D3SCR4GZ -
RxCUI
2639021 -
RxCUI
2639027 -
RxCUI
2639029 -
RxCUI
2639030 -
RxCUI
2639031 -
RxCUI
2639032 -
RxCUI
2639033 -
RxCUI
2639034 -
RxCUI
2639036 -
RxCUI
2639039 -
RxCUI
2639041 -
RxCUI
2639042 -
RxCUI
2639043 -
RxCUI
2639044
What the source publishes
- Labeler
- Braeburn Inc.
- Active ingredients
- BUPRENORPHINE
- Form
- INJECTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "BRIXADI",
"splId": "4e1985eb-1302-42e0-ac79-10b0a492966a",
"labels": [
{
"setId": "5d8a8fd0-8619-422a-a664-d1d2e8970f48",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d8a8fd0-8619-422a-a664-d1d2e8970f48",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d8a8fd0-8619-422a-a664-d1d2e8970f48"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Braeburn Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (58284-264-01) / .18 mL in 1 SYRINGE, GLASS",
"package_ndc": "58284-264-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20230606"
}
],
"productId": "58284-264_4e1985eb-1302-42e0-ac79-10b0a492966a",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "58284-264",
"deaSchedule": "CIII",
"genericName": "BUPRENORPHINE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BUPRENORPHINE",
"strength": "64 mg/.18mL"
}
],
"applicationNumber": "NDA210136",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230606",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175689",
"N0000175685"
],
"unii": [
"40D3SCR4GZ"
],
"rxcui": [
"2639021",
"2639027",
"2639029",
"2639030",
"2639031",
"2639032",
"2639033",
"2639034",
"2639036",
"2639039",
"2639041",
"2639042",
"2639043",
"2639044"
],
"spl_set_id": [
"5d8a8fd0-8619-422a-a664-d1d2e8970f48"
],
"pharm_class_epc": [
"Partial Opioid Agonist [EPC]"
],
"pharm_class_moa": [
"Partial Opioid Agonists [MoA]"
],
"manufacturer_name": [
"Braeburn Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:58284-264_4e1985eb-1302-42e0-ac79-10b0a492966a"